0.855
price up icon5.83%   0.047
 
loading

Finanzdaten der Renovorx Inc-Aktie (RNXT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
21.11%
0.213
0.27 0.103 0.043 -
Operating Expenses
15.77%
3.413
2.948 3.213 2.675 2.828
Benefits Costs and Expenses
1.26%
3.125
3.165 2.523 - -
Costs And Expenses
15.77%
3.413
2.948 3.213 - -
Operating Income/Loss
19.49%
-3.20
-2.678 -3.11 -2.632 -2.828
Nonoperating Income/Loss
232.72%
0.288
-0.217 0.69 -0.246 0.357
Income/Loss From Continuing Operations Before Tax
0.59%
-2.912
-2.895 -2.42 -2.878 -2.471
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
0.59%
-2.912
-2.895 -2.42 -2.878 -2.471
Net Income/Loss
0.59%
-2.912
-2.895 -2.42 -2.878 -2.471
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.19%
36.65
36.58 31.40 0.9455 24.94
Diluted Average Shares
0.19%
36.65
36.58 31.40 0.9455 24.94
Basic Earnings Per Share
0.00%
-0.08
-0.08 -0.08 -0.12 -0.10
Diluted Earnings Per Share
0.00%
-0.08
-0.08 -0.08 -0.12 -0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):